Company: INKT
Filing Date: 2025-01-21
Form Type: 8-K
Source: 0001193125-25-009595
Chunk: 2

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-01-21
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                                   
                                                                                                                             
      No.                                                                                                                    
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      3.1      Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MiNK Therapeutics, Inc.  
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                                  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: January 21, 2025      By:      /s/ Jennifer Buell, Ph. D.                 
 ──────────────────────────────────────────────────────────────────────────────────
                                       Jennifer Buell, Ph. D., President and CEO